Medscape (9/2, Barclay) reported that "persistent decreases in bone mineral density (BMD) may affect the risk for future postmenopausal osteoporotic fractures in adulthood" in young women with type 1 diabetes, according to research published in the September issue of the journal Diabetes Care. For the study, "at baseline and two years later, 63 women with type 1 diabetes and 85 age-matched, community control subjects underwent BMD measurement by dual-energy x-ray absorptiometry." The "investigators also evaluated hemoglobin A1c, insulin growth factor-1, insulin growth factor–binding protein-3, serum osteocalcin, and urine N-telopeptide." The authors found that, "compared with control subjects, women 20 years or older with type 1 diabetes continued to have lower total hip, femoral neck, and whole-body BMD at year two." Based on their study results, the researchers concluded that even though "bone density testing is not routinely performed in young women...screening may be important in young women with type 1 diabetes." In addition, they suggested that "these women should be counseled regarding lifestyle interventions that may improve bone health, including adequate intake of calcium and vitamin D, and exercise."